PRAME Antikörper (N-Term)
Kurzübersicht für PRAME Antikörper (N-Term) (ABIN6743940)
Target
Alle PRAME Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- Human PRAME
-
Homologie
- Percent identity by BLAST analysis: Human (100%) Horse (92%) Bovine (85%) Rat, Pig (84%).
-
Aufreinigung
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide from N-Terminus of human PRAME (P78395, NP_006106). Percent identity by BLAST analysis: Human, Gorilla, Gibbon, Monkey (100%), Horse (92%), Bovine, Pig (85%), Rat (84%).
Type of Immunogen: Synthetic peptide
-
-
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 416-502) antibody
PRAME Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 151-250) antibodyPRAME Reaktivität: Human, Maus ELISA, FACS, IF (cc), IF (p), ICC, IHC (p), IHC (fro) Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reaktivität: Human WB, IP, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reaktivität: Human IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 476-502), (C-Term) antibodyPRAME Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal RB18763 unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-509) antibodyPRAME Reaktivität: Human WB Wirt: Maus Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 416-502) antibodyPRAME Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 1-200) antibodyPRAME Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 71-120) antibodyPRAME Reaktivität: Human, Pferd, Schwein, Kaninchen WB Wirt: Kaninchen Polyclonal unconjugated
anti-Preferentially Expressed Antigen in Melanoma (PRAME) (AA 460-510) antibodyPRAME Reaktivität: Human, Rind (Kuh), Pferd, Affe, Hund WB Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
-
Approved: WB (0.2 - 1 μg/mL)
Usage: Western Blot: Suggested dilution at 1 μg/mL in 5 % skim milk / PBS buffer, and HRP conjugated anti-Rabbit IgG should be diluted in 1: 50,000 - 100,000 as secondary antibody. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Distilled water
-
Konzentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))
-
Andere Bezeichnung
- PRAME
-
Hintergrund
-
Name/Gene ID: PRAME
Synonyms: PRAME, Cancer/testis antigen 130, CT130, MAPE, Opa-interacting protein 4, Opa-interacting protein OIP4, OIP-4, OIP4 -
Gen-ID
- 23532
-
NCBI Accession
- NP_006106
-
UniProt
- P78395
-
Pathways
- Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding
Target
-
